|
FAM173A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.019380E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.238830E-03 |
| Normal-vs-Stage2 |
1.825210E-04 |
| Normal-vs-Stage3 |
1.777720E-02 |
| Normal-vs-Stage4 |
5.532300E-02 |
| Stage1-vs-Stage2 |
6.249700E-02 |
| Stage1-vs-Stage3 |
2.611200E-01 |
| Stage1-vs-Stage4 |
1.528600E-01 |
| Stage2-vs-Stage3 |
1.755630E-02 |
| Stage2-vs-Stage4 |
1.215890E-02 |
| Stage3-vs-Stage4 |
7.324400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.244300E-04 |
| Normal-vs-AfricanAmerican |
8.429900E-02 |
| Normal-vs-Asian |
1.426480E-02 |
| Caucasian-vs-AfricanAmerican |
4.761400E-01 |
| Caucasian-vs-Asian |
9.662400E-01 |
| AfricanAmerican-vs-Asian |
6.029800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.262520E-03 |
| Normal-vs-Female |
3.847400E-04 |
| Male-vs-Female |
8.873600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.163900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.815920E-03 |
| Normal-vs-Age(61-80Yrs) |
4.162900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.041000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.391400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.143200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.481600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.802200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.319000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.406200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.962700E-03 |
| Classical-VS-Follicular |
1.426190E-04 |
| Classical-VS-Other |
2.122800E-01 |
| Classical-VS-Normal |
8.018100E-03 |
| Tall-VS-Follicular |
2.84169999975603E-07 |
| Tall-VS-Other |
9.360600E-03 |
| Tall-VS-Normal |
8.228800E-01 |
| Follicular-VS-Other |
7.675000E-01 |
| Follicular-VS-Normal |
3.45769999965384E-07 |
| Other-VS-Normal |
2.232400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.81979999997117E-06 |
| Normal-vs-N1 |
3.019900E-04 |
| N0-vs-N1 |
7.437400E-01 |
|
|
